生物标志物 生物标志物
Sarah A Scalzo1, Elias G Seath1, Rachel L Studer2
1Department of Medicine, Division of Geriatrics and Gerontology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
这项研究发现COVID-19感染与阿尔茨海默病生物标志物或流行前后队列的认知变化之间没有显著的联系. 需要进一步的研究来澄清潜在的长期神经效应.
科学领域:
- 神经科学是一个神经科学.
- 传染病流行病学 传染病流行病学
- 生物标志物研究 生物标志物研究
背景情况:
- 阿尔茨海默氏病 (AD) 的发病包括神经炎症,可能受到COVID-19等外围疾病的影响.
- COVID-19对AD生物标志物和认知功能的影响仍然在很大程度上未被描述.
- 研究这些关系对于理解病毒感染潜在的神经系统后果至关重要.
研究的目的:
- 为了检查COVID-19感染和阿尔茨海默病 (AD) 生物标志物的变化之间的关联.
- 通过使用大流行前和后的数据,评估COVID-19对认知表现的影响.
- 探索神经炎症,COVID-19和AD进展之间的关系.
主要方法:
- 利用了来自威斯康星州阿尔茨海默病预防登记处的数据,比较了疫情前和后的访问.
- 分析了与COVID-19状态和阳性相关的年化生物标志物变化 (例如,pTau217).
- 与基线调整的认知评分进行比较,使用COVID-19阳性与阴性参与者的t测试.
主要成果:
- 在对多次比较进行校正后,在COVID-19阳性和阴性组之间没有观察到生物标志物水平的显著差异.
- 认知测试结果显示,与之前的发现相反,COVID-19阳性组的高分趋势不显著,与之前的发现相反.
- 在COVID-19阳性组中发现了更高的疫苗接种率.
结论:
- 该研究发现,COVID-19感染,认知测试表现或阿尔茨海默病生物标志物水平之间没有显著的关联.
- 高疫苗接种率和潜在的混因素,如COVID-19阳性组中的年龄较小,可能会限制研究结果的可靠性.
- 优势包括纵向生物标志物和认知数据,个体评分解释,以及大型的风险队列.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516